These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
660 related items for PubMed ID: 16232370
1. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. Minkina-Pedras M, Jarosz-Chobot P, Małecka-Tendera E, Deja G. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370 [Abstract] [Full Text] [Related]
3. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion. Pańkowska E, Szypowska A, Lipka M, Skórka A. Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017 [Abstract] [Full Text] [Related]
4. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C. Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064 [Abstract] [Full Text] [Related]
5. Insulin requirement in preschoolers treated with insulin pumps at the onset of type 1 diabetes mellitus. Szypowska A, Lipka M, Błazik M, Groele L, Pańkowska E. Acta Paediatr; 2009 Mar; 98(3):527-30. PubMed ID: 19021593 [Abstract] [Full Text] [Related]
8. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion. Szypowska A, Lipka M, Błazik M, Golicka D, Groele L, Pańkowska E. Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348 [Abstract] [Full Text] [Related]
12. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus]. Hasselmann C, Bonnemaison E, Faure N, Mercat I, Bouillo Pépin-Donat M, Magontier N, Chantepie A, Labarthe F. Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198 [Abstract] [Full Text] [Related]
13. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents. Kapellen TM, Heidtmann B, Bachmann J, Ziegler R, Grabert M, Holl RW. Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157 [Abstract] [Full Text] [Related]
15. Metabolic control with insulin pump therapy: the Waikato experience. Reda E, Von Reitzenstein A, Dunn P. N Z Med J; 2007 Jan 26; 120(1248):U2401. PubMed ID: 17277817 [Abstract] [Full Text] [Related]
18. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes. Júlíusson PB, Graue M, Wentzel-Larsen T, Søvik O. Acta Paediatr; 2006 Nov 26; 95(11):1481-7. PubMed ID: 17062481 [Abstract] [Full Text] [Related]
19. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M. Exp Clin Endocrinol Diabetes; 2009 Sep 26; 117(8):378-85. PubMed ID: 19629931 [Abstract] [Full Text] [Related]